NGM Biopharmaceuticals Inc
NGM
Equity
ISIN null / Valor 44000298
NASDAQ (2024-04-04)
USD 1.54-1.28%
NGM Biopharmaceuticals Inc
UMushroom community rating:
About company
NGM Biopharmaceuticals Inc is a biopharmaceutical company dedicated to the discovery and development of innovative medicines aimed at improving the lives of individuals affected by various diseases. Their focus lies in creating groundbreaking treatments that have the potential to significantly impact the health and well-being of patients.
Summarized from source with an LLMView SourceSector:Key figures
-61.1%1Y
-94.8%3Y
-89.5%5Y
Performance
23.6%1Y
116%3Y
95.5%5Y
Volatility
314 M
Market cap (USD)
997,938
Daily traded volume (Shares)
1.57 / 1.54
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
0.002022
0.002023
0.002024
Est dividend (USD)
0.00%2022
0.00%2023
0.00%2024
Est dividend yield
P/E ratio
00.002022
00.002023
00.002024
Est P/E ratio
EPS (USD)
0.002022
0.002023
0.002024
Est EPS (USD)
Ratings & reviews
Performance:
0.00
Innovation:
0.00
Society:
0.00
Nature:
0.00
